Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate
- 1 March 2002
- journal article
- Published by Elsevier BV in American Journal of Ophthalmology
- Vol. 133 (3), 373-385
- https://doi.org/10.1016/s0002-9394(01)01381-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.Diabetes, 1998
- Upregulation of Retinal Vascular Endothelial Growth Factor mRNAs in Spontaneously Diabetic Rats without Ophthalmoscopic RetinopathyOphthalmic Research, 1998
- VEGF localisation in diabetic retinopathyBritish Journal of Ophthalmology, 1998
- Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changesDiabetologia, 1997
- Localization of Vascular Endothelial Growth Factor in Human Retina and ChoroidAmerican Journal of Ophthalmology, 1996
- Vascular Endothelial Growth Factor Is Sufficient to Produce Iris Neovascularization and Neovascular Glaucoma in a Nonhuman PrimateAmerican Journal of Ophthalmology, 1996
- Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.Proceedings of the National Academy of Sciences of the United States of America, 1995
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994
- Detection of Vascular Endothelial Growth Factor Messenger RNA and Vascular Endothelial Growth Factor-like Activity in Proliferative Diabetic RetinopathyAmerican Journal of Ophthalmology, 1994
- Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic RetinopathyAmerican Journal of Ophthalmology, 1994